Related Experiment Video
Updated: Dec 10, 2025
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcal meningitis and COVID-19 co-infection
Stuart Declan Gallacher1, Andrew Seaton2
1Department of Medical Microbiology, Queen Elizabeth University Hospital, Glasgow, UK stuartgallacher@nhs.net.
Abstract:
Bacterial co-infection in the ongoing pandemic of COVID-19 is associated with poor outcomes but remains little understood. A 22-year-old woman presented with a 3-week history of fever, headache, neck stiffness, rigours and confusion. She was noted to have a purpuric rash over her hands and feet. Cerebrospinal fluid bacterial PCR was positive for Neisseria meningitidis A concurrent nasopharyngeal RT-PCR was positive for SARS-CoV-2, the causative virus of COVID-19. She was treated with antibiotics for bacterial meningitis and made a complete recovery. Bacterial infection from nasopharyngeal organisms has followed previous pandemic viral upper respiratory illnesses and the risk of bacterial co-infection in COVID-19 remains unclear. Research characterising COVID-19 should specify the frequency, species and outcome of bacterial co-infection. Management of bacterial co-infection in COVID-19 presents major challenges for antimicrobial stewardship and clinical management. Judicious use of local antibiotic guidelines and early liaison with infection specialists is key.
Insights
COVID-19 patients can experience bacterial co-infections, such as meningococcal meningitis, alongside SARS-CoV-2. Early antibiotic treatment is crucial for recovery and managing these serious co-infections.
Area of Science:
- Infectious Diseases
- Virology
- Bacteriology
Background:
- Bacterial co-infections complicate viral pandemics like COVID-19, yet remain poorly understood.
- Previous viral respiratory illnesses have been followed by bacterial infections from nasopharyngeal organisms.
Observation:
- A 22-year-old female presented with symptoms of meningitis and COVID-19.
- Cerebrospinal fluid analysis revealed *Neisseria meningitidis*, and nasopharyngeal PCR confirmed SARS-CoV-2.
Findings:
- The patient received antibiotics for bacterial meningitis and fully recovered.
- This case highlights the potential for severe bacterial co-infection in COVID-19 patients.
Implications:
- Further research is needed to determine the frequency, species, and outcomes of bacterial co-infections in COVID-19.
- Effective management requires adherence to local antibiotic guidelines and prompt consultation with infection specialists.
- Antimicrobial stewardship and clinical management face significant challenges due to bacterial co-infections in COVID-19.
Related Concept Videos
01:29Pneumonia II: Pathophysiology
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:19Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...